HOME >> BIOLOGY >> NEWS
Einstein's Dr. Vern Schramm elected to the National Academy of Sciences

May 1, 2007 (BRONX, NY) -- Vern L. Schramm, Ph.D., Professor and Ruth Merns Chair of Biochemistry at the Albert Einstein College of Medicine of Yeshiva University, has been elected to the National Academy of Sciences, the nations most prestigious honorary society for scientists. His election was announced today at the Academys annual meeting in Washington, D.C.

Dr. Schramm has been a member of the Einstein faculty since 1987. Throughout his career, he has carried out groundbreaking research into the mechanisms involved in enzymatic reactions. This work has led to promising drugs now being tested in clinical trials for treating autoimmune diseases and several types of cancer.

Dr. Schramm studies the transition-state structure of enzyme-catalyzed reactions the shapes that reacting molecules assume when enzymes catalyze chemical reactions. As he describes it, Enzymes govern virtually all of the chemical transformations necessary for biological life but can also influence cells to become cancerous. By knowing the transition-state structure of enzyme-catalyzed reactions, we can design powerful inhibitors that can block those enzymes from acting and thereby treat or prevent cancer and other diseases.

One such inhibitor that Dr. Schramm has designed, known as Immucillin-H, is a promising anticancer agent for treating T-cell malignancies. It is currently in a pivotal phase IIb clinical trial (specifically targeted to study efficacy) at sites in the U.S., eastern and western Europe, and South America.

Another transition-state inhibitor developed by Dr. Schramm is now being studied as a possible treatment for autoimmune diseases such as psoriasis, rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disorders and for preventing the rejection of transplanted organs.

The election to the Academy is the latest among numerous honors recognizing Dr. Schramms many contributions in more than 35 years as a biochemistr
'"/>

Contact: Karen Gardner
kgardner@aecom.yu.edu
718-430-3101
Albert Einstein College of Medicine
4-May-2007


Page: 1 2

Related biology news :

1. Einsteins Dr. E. Richard Stanley receives 2006 E. Donnall Thomas Prize
2. Einsteins Susan Band Horwitz, PhD wins Bristol-Myers Squibb Cancer Research Award
3. Candidate research sites selected for the National Ecological Observatory Network
4. Depiction of findings selected as 2007 Image of the Year by Society for Nuclear Medicine
5. CSHL selected for odENCODE Data Coordination Center
6. University of Arizona neurobiologist John Hildebrand elected to the National Academy of Sciences
7. 5 Stanford professors elected to National Academy of Sciences
8. Salk scientist Ursula Bellugi elected to National Academy of Sciences
9. Psychology professor elected to American Academy of Arts and Sciences
10. ORNLs Thundat elected fellow of AAAS
11. Leading scientists elected to EMBO ranks

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2017)... , April 13, 2017 According to a new ... Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, ... IAM Market is expected to grow from USD 14.30 Billion in 2017 ... (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... MELBOURNE, Florida , April 11, 2017 ... "Company"), a security technology company, announces the appointment of independent ... John Bendheim to its Board of Directors, furthering the ... ... behalf of NXT-ID, we look forward to their guidance and ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... ... it will be hosting a Webinar titled, “Pathology is going digital. Is your ... on digital pathology adoption best practices and how Proscia improves lab economics and ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... firm Parks Associates announced today that Tom Kerber , ... Meeting , October 11 in Scottsdale, Arizona . Kerber ... smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction ...
(Date:10/9/2017)... ... 2017 , ... The award-winning American Farmer television series will feature 3 Bar ... Tuesdays at 8:30aET on RFD-TV. , With global population estimates nearing ten billion ... continue to feed a growing nation. At the same time, many of our valuable ...
Breaking Biology Technology:
Cached News: